Rachel K. King

2013

In 2013, Rachel K. King earned a total compensation of $455.2K as President and Chief Executive Officer at GlycoMimetics.

Compensation breakdown

Non-Equity Incentive Plan$89,585
Salary$365,650
Total$455,235

King received $365.7K in salary, accounting for 80% of the total pay in 2013.

King also received $89.6K in non-equity incentive plan.

Rankings

In 2013, Rachel K. King's compensation ranked 9,656th out of 12,286 executives tracked by ExecPay. In other words, King earned more than 21.4% of executives.

ClassificationRankingPercentile
All
9,656
out of 12,286
21st
Division
Manufacturing
3,576
out of 4,612
23rd
Major group
Chemicals And Allied Products
1,130
out of 1,462
23rd
Industry group
Drugs
877
out of 1,156
24th
Industry
Pharmaceutical Preparations
686
out of 890
23rd
Source: SEC filing on June 15, 2015.

King's colleagues

We found three more compensation records of executives who worked with Rachel K. King at GlycoMimetics in 2013.

2013

Helen Thackray

GlycoMimetics

Chief Medical Officer

2013

John Magnani

GlycoMimetics

Chief Scientific Officer

2013

Brian Hahn

GlycoMimetics

Chief Financial Officer

News

You may also like